日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer

Patritumab Deruxtecan (HER3-DXd) 在 EGFR 抑制剂耐药、EGFR 突变型非小细胞肺癌中的疗效和安全性

Jänne, Pasi A; Baik, Christina; Su, Wu-Chou; Johnson, Melissa L; Hayashi, Hidetoshi; Nishio, Makoto; Kim, Dong-Wan; Koczywas, Marianna; Gold, Kathryn A; Steuer, Conor E; Murakami, Haruyasu; Yang, James Chih-Hsin; Kim, Sang-We; Vigliotti, Michele; Shi, Rong; Qi, Zhenhao; Qiu, Yang; Zhao, Lihui; Sternberg, David; Yu, Channing; Yu, Helena A

Protein Electrostatics Investigated through Paramagnetic NMR for Nonpolar Groups

通过顺磁核磁共振研究非极性基团的蛋白质静电

Binhan Yu, Channing C Pletka, Junji Iwahara

Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib

转移性去势抵抗性前列腺癌中 c-MET 和雄激素受体的双重阻断:恩扎卢胺和克唑替尼联合治疗的 I 期研究

Tripathi, Abhishek; Supko, Jeffrey G; Gray, Kathryn P; Melnick, Zachary J; Regan, Meredith M; Taplin, Mary-Ellen; Choudhury, Atish D; Pomerantz, Mark M; Bellmunt, Joaquim; Yu, Channing; Sun, Zijie; Srinivas, Sandy; Kantoff, Philip W; Sweeney, Christopher J; Harshman, Lauren C

Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

更正:酪氨酸激酶抑制剂对伊马替尼耐药性胃肠道间质瘤中继发性kit突变的互补活性

Serrano, César; Mariño-Enríquez, Adrián; Tao, Derrick L; Ketzer, Julia; Eilers, Grant; Zhu, Meijun; Yu, Channing; Mannan, Aristotle M; Rubin, Brian P; Demetri, George D; Raut, Chandrajit P; Presnell, Ajia; McKinley, Arin; Heinrich, Michael C; Czaplinski, Jeffrey T; Sicinska, Ewa; Bauer, Sebastian; George, Suzanne; Fletcher, Jonathan A

High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines.

利用条形码标记的肿瘤细胞系混合物进行高通量基因型特异性癌症脆弱性鉴定

Yu Channing, Mannan Aristotle M, Yvone Griselda Metta, Ross Kenneth N, Zhang Yan-Ling, Marton Melissa A, Taylor Bradley R, Crenshaw Andrew, Gould Joshua Z, Tamayo Pablo, Weir Barbara A, Tsherniak Aviad, Wong Bang, Garraway Levi A, Shamji Alykhan F, Palmer Michelle A, Foley Michael A, Winckler Wendy, Schreiber Stuart L, Kung Andrew L, Golub Todd R

Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo.

靶向删除 GATA-1 启动子中的高亲和力 GATA 结合位点,会导致体内嗜酸性粒细胞谱系的选择性丧失

Yu Channing, Cantor Alan B, Yang Haidi, Browne Carol, Wells Richard A, Fujiwara Yuko, Orkin Stuart H